221 related articles for article (PubMed ID: 15262330)
21. Compensation in pre-synaptic dopaminergic function following nigrostriatal damage in primates.
McCallum SE; Parameswaran N; Perez XA; Bao S; McIntosh JM; Grady SR; Quik M
J Neurochem; 2006 Feb; 96(4):960-72. PubMed ID: 16412097
[TBL] [Abstract][Full Text] [Related]
22. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.
O'Dell SJ; Gross NB; Fricks AN; Casiano BD; Nguyen TB; Marshall JF
Neuroscience; 2007 Feb; 144(3):1141-51. PubMed ID: 17157992
[TBL] [Abstract][Full Text] [Related]
23. 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.
Whiteaker P; McIntosh JM; Luo S; Collins AC; Marks MJ
Mol Pharmacol; 2000 May; 57(5):913-25. PubMed ID: 10779374
[TBL] [Abstract][Full Text] [Related]
24. [Possible involvement of neuronal nicotinic acetylcholine receptors in compensatory brain mechanisms at early stages of Parkinson's disease].
Kryukova EV; Shelukhina IV; Kolacheva AA; Alieva AK; Shadrina MI; Slominsky PA; Kasheverov IE; Utkin YN; Ugrumov MV; Tsetlin VI
Biomed Khim; 2017 May; 63(3):241-247. PubMed ID: 28781257
[TBL] [Abstract][Full Text] [Related]
25. Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism.
Brown AM; Deutch AY; Colbran RJ
Eur J Neurosci; 2005 Jul; 22(1):247-56. PubMed ID: 16029214
[TBL] [Abstract][Full Text] [Related]
26. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
Sconce MD; Churchill MJ; Greene RE; Meshul CK
Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
[TBL] [Abstract][Full Text] [Related]
27. GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action.
Schober A; Peterziel H; von Bartheld CS; Simon H; Krieglstein K; Unsicker K
Neurobiol Dis; 2007 Feb; 25(2):378-91. PubMed ID: 17141511
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
Callier S; Morissette M; Grandbois M; Pélaprat D; Di Paolo T
Synapse; 2001 Aug; 41(2):131-8. PubMed ID: 11400179
[TBL] [Abstract][Full Text] [Related]
29. α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease.
Perez XA; Bordia T; McIntosh JM; Quik M
Mol Pharmacol; 2010 Nov; 78(5):971-80. PubMed ID: 20732972
[TBL] [Abstract][Full Text] [Related]
30. Exercise in an animal model of Parkinson's disease: Motor recovery but not restoration of the nigrostriatal pathway.
Churchill MJ; Pflibsen L; Sconce MD; Moore C; Kim K; Meshul CK
Neuroscience; 2017 Sep; 359():224-247. PubMed ID: 28754312
[TBL] [Abstract][Full Text] [Related]
31. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
32. Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.
Quik M; McIntosh JM
J Pharmacol Exp Ther; 2006 Feb; 316(2):481-9. PubMed ID: 16210393
[TBL] [Abstract][Full Text] [Related]
33. Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum.
O'Leary K; Parameswaran N; McIntosh JM; Quik M
J Pharmacol Exp Ther; 2008 May; 325(2):646-54. PubMed ID: 18305015
[TBL] [Abstract][Full Text] [Related]
34. Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey.
Quik M; Police S; Langston JW; Di Monte DA
Neuroscience; 2002; 113(1):213-20. PubMed ID: 12123699
[TBL] [Abstract][Full Text] [Related]
35. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
Guigoni C; Dovero S; Aubert I; Li Q; Bioulac BH; Bloch B; Gurevich EV; Gross CE; Bezard E
Eur J Neurosci; 2005 Jul; 22(1):283-7. PubMed ID: 16029219
[TBL] [Abstract][Full Text] [Related]
36. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease.
Tillerson JL; Caudle WM; Reverón ME; Miller GW
Neuroscience; 2003; 119(3):899-911. PubMed ID: 12809709
[TBL] [Abstract][Full Text] [Related]
37. Chronic nicotine treatment increases nAChRs and microglial expression in monkey substantia nigra after nigrostriatal damage.
Quik M; Campos C; Parameswaran N; Langston JW; McIntosh JM; Yeluashvili M
J Mol Neurosci; 2010 Jan; 40(1-2):105-13. PubMed ID: 19685015
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
39. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
40. Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs.
Khwaja M; McCormack A; McIntosh JM; Di Monte DA; Quik M
J Neurochem; 2007 Jan; 100(1):180-90. PubMed ID: 17227438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
